Facebook Twitter YouTube Google Plus

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

David S. Ettinger, MD
Johns Hopkins University

David S. Ettinger, MD, is the Alex Grass Professor of Oncology at the Johns Hopkins University School of Medicine in Baltimore, Maryland.  He also holds four additional professorships – professor of medicine, professor of otolaryngology - head and neck surgery, professor of gynecology and obstetrics, and professor of radiation oncology and molecular radiation sciences. Dr. Ettinger received his medical degree from the University of Louisville School of Medicine.  He completed his training in medical oncology at Johns Hopkins in 1975, and since then has been on the faculty of the School of Medicine.  Dr. Ettinger’s research interests are in new drug development and innovative multidisciplinary cancer treatment strategies.  He is also interested in improving supportive care measures associated with cancer and its treatment.  Dr. Ettinger has authored or co-authored over 190 articles and serves as an editor for Current Treatment Options in Oncology.

To view this video presentation, please click on the image below.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion